Investors in This Top Marijuana Stock Can’t Overlook These 2 Serious Challenges

Big things are happening in the cannabis industry — especially with our neighbor to the north. In 34 days, on Oct. 17, recreational marijuana can be legally sold in licensed dispensaries in Canada. And with its legalization, the industry will be angling for somewhere in the neighborhood of $5 billion in annual sales.

But there’s more going on with the weed industry than just Canada lifting the curtain on adult-use marijuana in Canada. There are big things happening in the United States, too. Among the numerous marijuana firsts this year was the approval of the very first cannabis-derived drug by the U.S. Food and Drug Administration (FDA) on June 25.

Image source: Getty Images.

The very first cannabis-derived drug gets the green light

U.K.-based GW Pharmaceuticals (NASDAQ:GWPH) made history when the FDA gave the green light to its cannabidiol (CBD)-based oral solution known as Epidiolex for two rare

... read more at: https://www.fool.com/investing/2018/09/13/investors-in-this-top-marijuana-stock-cant-overloo.aspx

by